[Federal Register Volume 72, Number 173 (Friday, September 7, 2007)]
[Notices]
[Page 51460]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 07-4366]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Allergy and Infectious Diseases; Notice of 
Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The contract proposals and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the contract proposals, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel, Phase I Clinical Trial Units for 
Therapeutics Against Infectious Diseases.
    Date: September 28, 2007.
    Time: 8 a.m. to 6 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: Hilton Washington/Rockville, 1750 Rockville Pike, 
Rockville, MD 20852.
    Contact Person: Brenda Lange-Gustafson, PhD, Scientific Review 
Administrator, NIAID, DEA, Scientific Review Program, Room 3122, 
6700-B Rockledge Drive, MSC-7616, Bethesda, MD 20892-7616, 301-451-
3684, [email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, 
Allergy, Immunology, and Transplantation Research; 93.856, 
Microbiology and Infectious Diseases Research, National Institutes 
of Health, HHS)

    August 28, 2007.
Anna Snouffer,
Deputy Director, Office of Federal Advisory Committee Policy.
[FR Doc. 07-4366 Filed 9-6-07; 8:45 am]
BILLING CODE 4140-01-M